Hemolytic-Uremic Syndrome Latest Advances

Urgent-start peritoneal dialysis in a large pediatric STEC-HUS outbreak: Clinical and operational rationale.

Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Published: April 06, 2026

Clinical efficacy and safety of eculizumab in pediatric atypical hemolytic uremic syndrome

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: March 16, 2026

Shiga Toxin-Producing Escherichia coli Outbreak in Canadian Daycare Centers.

Journal: JAMA network open

Published: March 10, 2026

Hematologic disorders in pregnancy: the role of the complement system.

Journal: Expert review of hematology

Published: March 05, 2026

Nationwide outbreak of Shiga toxin-producing Escherichia coli infections associated with frozen pizzas, France, 2022.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 27, 2026

Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome: a post hoc analysis of a phase 2 clinical trial.

Journal: Journal of clinical microbiology

Published: February 27, 2026

Pathogenic potential and phylogenomic analysis of stx2-carrying O26:H11 Shiga toxin-producing Escherichia coli isolated from dairy products in France (2014-2024).

Journal: Microbial genomics

Published: February 19, 2026

Pneumococcal HUS in infancy masking DGKE-related thrombotic microangiopathy with secondary hemophagocytic lymphohistiocytosis.

Journal: Pediatric nephrology (Berlin, Germany)

Published: February 14, 2026

Recurrent Atypical Hemolytic-Uremic Syndrome (aHUS) Associated With CD46 Genetic Mutation: A Report of a Rare Case.

Journal: Cureus

Published: February 12, 2026

Shiga Toxin 1a Blunts Shiga Toxin 2a-pathogenic Effects in Blood.

Journal: Thrombosis and haemostasis

Published: February 06, 2026

Practical Considerations for Infection Prevention with the Clinical Use of Complement Inhibitors.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: February 06, 2026

A 'complement' problem: Complement-mediated hemolytic uremic syndrome triggered by Klebsiella pneumoniae liver abscess.

Journal: The American journal of medicine

Published: February 05, 2026

Hemolytic-Uremic Syndrome Latest Advances

Find the Latest Research About Hemolytic-Uremic Syndrome

Urgent-start peritoneal dialysis in a large pediatric STEC-HUS outbreak: Clinical and operational rationale.

Urgent-start peritoneal dialysis in a large pediatric STEC-HUS outbreak: Clinical and operational rationale.

Clinical efficacy and safety of eculizumab in pediatric atypical hemolytic uremic syndrome

Clinical efficacy and safety of eculizumab in pediatric atypical hemolytic uremic syndrome

Shiga Toxin-Producing Escherichia coli Outbreak in Canadian Daycare Centers.

Shiga Toxin-Producing Escherichia coli Outbreak in Canadian Daycare Centers.

Hematologic disorders in pregnancy: the role of the complement system.

Hematologic disorders in pregnancy: the role of the complement system.

Nationwide outbreak of Shiga toxin-producing Escherichia coli infections associated with frozen pizzas, France, 2022.

Nationwide outbreak of Shiga toxin-producing Escherichia coli infections associated with frozen pizzas, France, 2022.

Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome: a post hoc analysis of a phase 2 clinical trial.

Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome: a post hoc analysis of a phase 2 clinical trial.

Pathogenic potential and phylogenomic analysis of stx2-carrying O26:H11 Shiga toxin-producing Escherichia coli isolated from dairy products in France (2014-2024).

Pathogenic potential and phylogenomic analysis of stx2-carrying O26:H11 Shiga toxin-producing Escherichia coli isolated from dairy products in France (2014-2024).

Pneumococcal HUS in infancy masking DGKE-related thrombotic microangiopathy with secondary hemophagocytic lymphohistiocytosis.

Pneumococcal HUS in infancy masking DGKE-related thrombotic microangiopathy with secondary hemophagocytic lymphohistiocytosis.

Recurrent Atypical Hemolytic-Uremic Syndrome (aHUS) Associated With CD46 Genetic Mutation: A Report of a Rare Case.

Recurrent Atypical Hemolytic-Uremic Syndrome (aHUS) Associated With CD46 Genetic Mutation: A Report of a Rare Case.

Shiga Toxin 1a Blunts Shiga Toxin 2a-pathogenic Effects in Blood.

Shiga Toxin 1a Blunts Shiga Toxin 2a-pathogenic Effects in Blood.

Practical Considerations for Infection Prevention with the Clinical Use of Complement Inhibitors.

Practical Considerations for Infection Prevention with the Clinical Use of Complement Inhibitors.

A 'complement' problem: Complement-mediated hemolytic uremic syndrome triggered by Klebsiella pneumoniae liver abscess.

A 'complement' problem: Complement-mediated hemolytic uremic syndrome triggered by Klebsiella pneumoniae liver abscess.